Bone Marrow Mesenchymal Stem Cell Transplantation Increases GAP-43 Expression via ERK1/2 and PI3K/Akt Pathways in Intracerebral Hemorrhage

Autor: Kaijie Wang, Huaxin Sheng, Yanxia Tian, Junling Gao, Changmeng Cui, Jianzhong Cui, Xiaohua Jiang, Ran Li, Ying Cui
Rok vydání: 2017
Předmět:
Male
0301 basic medicine
Pathology
Physiology
Stem cells
lcsh:Physiology
Rats
Sprague-Dawley

Phosphatidylinositol 3-Kinases
GAP-43 Protein
0302 clinical medicine
Medicine
lcsh:QD415-436
Cells
Cultured

Phosphoinositide-3 Kinase Inhibitors
Mitogen-Activated Protein Kinase 1
Mitogen-Activated Protein Kinase 3
lcsh:QP1-981
Neuroprotection
Up-Regulation
medicine.anatomical_structure
Stem cell
Axonal regeneration
Signal Transduction
medicine.medical_specialty
Morpholines
Bone Marrow Cells
Mesenchymal Stem Cell Transplantation
lcsh:Biochemistry
03 medical and health sciences
Animals
Regeneration
Protein kinase B
PI3K/AKT/mTOR pathway
Cerebral Hemorrhage
Flavonoids
Intracerebral hemorrhage
business.industry
Mesenchymal stem cell
Mesenchymal Stem Cells
medicine.disease
Axons
Rats
Transplantation
Disease Models
Animal

030104 developmental biology
Chromones
Bone marrow
business
Proto-Oncogene Proteins c-akt
030217 neurology & neurosurgery
Zdroj: Cellular Physiology and Biochemistry, Vol 42, Iss 1, Pp 137-144 (2017)
ISSN: 1421-9778
1015-8987
Popis: Background/Aims: Intracerebral hemorrhage (ICH) occurs in hypertensive patients and results in high rates of mortality and disability. This study determined whether bone marrow mesenchymal stem cell (BMSC) transplantation affects axonal regeneration and examined the underlying mechanisms after the administration of PD98059 (p-ERK1/2 inhibitor) or/ and LY294002 (PI3K inhibitor). The hypothesis that was intended to be tested was that BMSC transplantation regulates the expression of growth-associated protein-43 (GAP-43) via the ERK1/2 and PI3K/Akt signaling pathways. Methods: Seventy-five male rats (250–280 g) were subjected to intracerebral blood injection and then randomly received a vehicle, BMSCs, PD98059 or LY294002 treatment. Neurological deficits were evaluated prior to injury and at 1, 3 and 7 days post-injury. The expression of GAP-43, Akt, p-Akt, ERK1/2, and p-ERK1/2 proteins was measured by western blot analysis. Results: BMSC transplantation attenuated neurological deficits 3-7 days post-ICH. The expression of GAP-43 was increased 3 days following BMSC transplantation. However, this increase was inhibited by either PD98059 or LY294002 treatment. Treatment with both PD98059 and LY294002 was more effective than was treatment with an individual compound. Conclusion: BMSC transplantation could attenuate neurological deficits and activate axonal regeneration in this rat ICH model. The protective effects might be associated with increased GAP-43 expression by activating both the ERK1/2 and PI3K/Akt signaling pathways.
Databáze: OpenAIRE